Overview

Helping Stroke Patients With ThermoSuit Cooling

Status:
Recruiting
Trial end date:
2022-04-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to assess the feasibility of using the Life Recovery Systems ThermoSuit Device to induce therapeutic hypothermia (32-34°C) in victims of ischemic stroke. This feasibility clinical study will enroll a total of 30 patients with acute ischemic stroke at four clinical centers. Subjects will receive hypothermia plus conventional therapy (such as IV-tPA and/or neurothrombectomy therapies if indicated). Endpoints will include feasibility of cooling, adverse events, and neurological recovery in comparison with matched historical controls.
Phase:
N/A
Details
Lead Sponsor:
Life Recovery Systems
Collaborators:
Geisinger Clinic
Tulane University School of Medicine
Treatments:
Etomidate
Magnesium Sulfate
Plasminogen
Propofol
Tissue Plasminogen Activator